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Gene‑based association tests
using GWAS summary statistics
and incorporating eQTL
Xuewei Cao1, Xuexia Wang2, Shuanglin Zhang1 & Qiuying Sha1*
Although genome-wide association studies (GWAS) have been successfully applied to a variety
of complex diseases and identified many genetic variants underlying complex diseases via single
marker tests, there is still a considerable heritability of complex diseases that could not be
explained by GWAS. One alternative approach to overcome the missing heritability caused by
genetic heterogeneity is gene-based analysis, which considers the aggregate effects of multiple
genetic variants in a single test. Another alternative approach is transcriptome-wide association
study (TWAS). TWAS aggregates genomic information into functionally relevant units that map to
genes and their expression. TWAS is not only powerful, but can also increase the interpretability
in biological mechanisms of identified trait associated genes. In this study, we propose a powerful
and computationally efficient gene-based association test, called Overall. Using extended Simes
procedure, Overall aggregates information from three types of traditional gene-based association
tests and also incorporates expression quantitative trait locus (eQTL) information into a gene-based
association test using GWAS summary statistics. We show that after a small number of replications
to estimate the correlation among the integrated gene-based tests, the p values of Overall can
be calculated analytically. Simulation studies show that Overall can control type I error rates very
well and has higher power than the tests that we compared with. We also apply Overall to two
schizophrenia GWAS summary datasets and two lipids GWAS summary datasets. The results show
that this newly developed method can identify more significant genes than other methods we
compared with.
Although genome-wide association studies (GWAS) have successfully identified thousands of single nucleotide
polymorphisms (SNPs) associated with a wide range of complex human traits1,2, there is a common limitation in
which GWAS focus on only a single genetic variant with a trait at a time. This limitation may limit the power to
identify clinically or biologically significant genetic a ssociations3. Furthermore, many genome-wide significant
genetic variants are in linkage disequilibrium (LD). Different LD patterns can cause non-replicated results of the
same variant in different populations4,5. Therefore, several powerful gene-based statistical association tests, in
which the genetic information of all genetic variants in a gene is combined to obtain more informative results,
have been developed, such as the Burden Test (BT)6, the Sequence Kernel Association Test (SKAT)7, and the
Optimized SKAT (SKATO)8.
When individual-level genotype and phenotype data are not available, the traditional gene-based association
tests, BT, SKAT, and SKATO, can be extended by using GWAS summary statistics9. Currently, there are many
GWAS summary statistics available in public resources10. In GWAS summary statistics, the Z-scores of genetic
variants in a gene are assumed to asymptotically follow a multivariate normal distribution with a correlation
matrix among all genetic variants in a gene under the null h
 ypothesis11, where the correlation matrix can be
estimated by LD among the genetic variants in the g ene12,13. When individual-level data are not available, LD is
usually estimated using external reference p
 anels14,15 (i.e., 1000 Genomes P
 roject16). Due to the small sample size
of reference panels used to estimate LD, statistical noise (i.e., inflated type I error rates or large numbers of false
positives) often exists which needs to be accounted f or17,18. One way to reduce the statistical noise is to correct
the estimated LD by a regularization p
 rocedure19. In the regularization procedure, a statistical white Gaussian
noise is added to the LD matrix which is estimated by a reference panel. After correcting the estimated LD by
the regularization procedure, we can assume that, under the null hypothesis, the Z-scores from GWAS summary
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statistics asymptotically follow a multivariate normal distribution with the correlation matrix being the corrected
LD matrix among the genetic variants in a gene.
To increase statistical power in identifying genes that are associated with complex diseases, P
 rediXcan20 and
transcriptome-wide association s tudy12,21 (TWAS) were developed by incorporating expression quantitative
trait locus (eQTL) data into GWAS. As pointed out by Zhang et al.15, PrediXcan and TWAS can be viewed as a
simple weighted linear combination of genetic variants with an eQTL—derived weight. In fact, the genetic architecture of complex traits is rarely known in advance and is likely to vary from one region to another across the
genome and from one trait to another15. Therefore, only considering one single eQTL—derived weight, such as
in PrediXcan and TWAS, may lose statistical power in identifying significant genes. Zhang et al.15 developed an
omnibus test (OT) using Cauchy combination method to integrate association evidence obtained by BT, SKAT,
and SKATO based on GWAS summary data with multiple eQTL‐derived weights. They showed that OT using
multiple eQTL—derived weights had some potential advantages.
Inspired by the advantage of OT, in this paper, we propose a more powerful and computationally efficient
method, called Overall, to aggregate the information from three types of traditional gene-based association tests
(BT, SKAT, SKATO) with multiple eQTL—derived weights using GWAS summary statistics. To combine information from the three gene-based association tests, the Overall method utilizes the extended Simes p
 rocedure5,22.
To apply the Overall method, we first need to estimate the correlation matrix among the three gene-based association tests with eQTL—derived weights under the null hypothesis. We provide an estimation method using a
replication procedure23,24. The replication procedure only needs to be performed once to obtain the correlation
matrix for each gene. Then, the p-values of Overall can be analytically computed without using permutations.
To calculate the p-values of the three types of gene-based association tests (BT, SKAT, SKATO) using GWAS
summary statistics with eQTL—derived weights, we use the “sumFREGAT” package in R (https://cran.r-proje
ct.org/web/packages/sumFREGAT/index.html)9. Once we obtain the p-values of these three tests, the p-value
of our proposed method can be easily calculated using its theoretical distribution. Extensive simulation studies
show that Overall can control type I error rates well and has higher power than the comparison methods across
most of the simulation settings. Similar to Zhang et al.15, we apply our method to two schizophrenia (SCZ) and
two lipids trait (HDL) GWAS summary data sets. Compared with OT and other tests, the proposed method can
identify more significant genes. More interestingly, some significant genes reported by GWAS catalog are only
identified by our proposed method.

Statistical models and methods
Statistical models.

Consider a set of M genetic variants in a gene. Let Z = (Z1 , . . . , ZM )T be an M × 1 vector of Z-scores of the M genetic variants. Note that the Z-scores is either directly provided by publicly available
GWAS summary statistics or calculated from a GWAS individual-level genotype and phenotype data set. We
are interested in testing the null hypothesis H0 that none of the genetic variants in the gene is associated with a
trait, whereas the alternative hypothesis is that at least one genetic variant in the gene is associated with a trait.
Following Svishcheva et al.9, Gusev et al.12, and Yang et al.25, we assume Z = (Z1 , . . . , ZM )T ∼ MVN(0, R) under
the null hypothesis, where R is the correlation matrix among Z , which can be estimated by LD among the genetic
variants in the g ene12,13. If individual-level data are not available, LD can be estimated using external reference
panels (i.e., 1000 Genomes Project16). However, if the sample size of a reference panel is small, LD may not be
estimated correctly so that it will induce statistical noise (i.e., inflated type I error rates or large numbers of false
positives)17,18. One way to correct the estimated LD is to use a regularization procedure by adding a statistical
white Gaussian n
 oise9,19. Let IM be an M × M identity matrix, and the corrected correlation matrix U can be
defined as

U = aR + (1 − a)IM ,

0 ≤ a ≤ 1,

where a is a scalar tuning parameter which represents the coefficient of proportionality between the corrected
correlation matrix U and the original R estimated using an external reference panel. The optimal tuning parameter a can be estimated by maximizing the log-likelihood function of the distribution of Z ∼ MVN(0, U), that is,


â = arg max log (L(Z : 0, U)) .
a∈[0,1]



Then the corrected correlation
Û = âR + 1 − â IM . Therefore, under the null hypothesis, we consider
 matrix

Z = (Z1 , . . . , ZM )T ∼ MVN 0, Û .
Suppose that there are a total of K different eQTL—derived weights from gene expression data
 (i.e., Genotype
k for
Tissue Expression (GTEx) project (https://gtexportal.org/home/)), denoted as Ŵk = diag Ŵ1k , . . . , ŴM
k = 0, 1, . . . , K , where Ŵ0 = diag(1, . . . , 1) represents a status without using any weights. In order to avoid the
influence of the scale
among genetic
 variants within each weight, we first standardize the eQTL—derived weights

M  k
k = Ŵ k
Wk as Wm
Ŵ

m
m  for m = 1, . . . , M . Based on the k th standardized weight Wk , the weighted
m=1
Z-score Wk Z follows a multivariate normal distribution. That is,


ˆ k and 
ˆ k = Wk ÛWk .
Wk Z ∼ MVN 0, 
We extend the three types of gene-based association tests, B
 T6, SKAT7, and S KATO8, to incorporate the
eQTL—derived weights based on GWAS summary s tatistics9,26. For the kth eQTL—derived weight, the three
gene-based test statistics can be written as
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k
QBT
= Z T Wk 1M ,

k
= (Wk Z)T Wk Z,
QSKAT


k
k
k
,
QSKATO
= min (1 − ρ)QSKAT
+ ρQBT
ρ∈[0,1]

k follows a χ 2 distribution with
where 1M is an M × 1 vector with elements of all 1s. Under the null hypothesis, QBT
k
k
1 degree of freedom; QSKAT
follows a weighted sum of χ 2 distributions with 1 degree of freedom; and QSKATO
follows a mixture of χ 2 distribution8. The p-values of these three test statistics can be easily calculated using the
“sumFREGAT” package in R (https://cran.r-project.org/web/packages/sumFREGAT/index.html)9.

Overall method. To aggregate information from these three gene-based association tests with mul-

tiple eQTL—derived weights, we develop a novel method, called Overall, which utilizes the extended Simes
k
k , pk
procedure5,22. Let pBT
SKAT , pSKATO be the p-values of BT, SKAT, SKATO with kth eQTL—derived weight,
k = 0, 1, . . . , K , respectively, where k = 0 denotes a status without using any weights. Thus, there are a
weights. Let
total of L = 3(K + 1) p-values from these three gene-based association tests with different
 k
k
k
of the ascending
p-values, where p(1) = mink=0,...,K pBT
p(1) , . . . , p(L) be a sequence
, pSKATO
, pSKAT

 k
k
k
and p(L) = max k=0,...,K pBT , pSKAT
. Overall combines these L p-values using the extended Simes
, pSKATO
procedure5,22, and the p-value of Overall is defined as


me p(l)
,
poverall = Min
l=1,...,L
me(l)
where me is the effective number of p-values among the L gene-based association tests with multiple weights,
p(l) is the l th element of the ascending p-values, and me(l) is the effective number of p-values among the top l
association tests. We use a more robust measure to obtain the effective numbers me and me(l), which was proposed
by Li et al.5. The values of me(l) and me can be estimated as

me(l) = l −

l


[(i − 1)I(i > 1)] and me = me(L) ,

i=1

where i denotes the ith eigenvalue of the correlation matrix  of p-values from L association tests with multiple
weights (the estimation of  will be discussed in the next section), I(·) is an indicator function. If the L association tests are independent, all eigenvalues i equal 1, and me(l) = l for l = 1, . . . , L; if the L association tests are
perfectly dependent, then 1 = l which is the number of tests used to calculate me(l) and the other eigenvalues
equal 0. In this case, me(l) = l − (l − 1) = 1 for l = 1, . . . , L.
The R codes and a sample data set for the implementation of Overall are available at github https://github.
com/xueweic/Overall.

Estimation of  under the null hypothesis. To apply our proposed method, we need to estimate the

correlation matrix of p-values  under the null hypothesis. Since the exact correlations among all L gene-based
association tests are unknown, we perform the estimation procedure with B replications. For each replicate b,
b = 1, . . . , B, we implement the following two steps:
Step 1: We first generate a new Z-score vector Z null under the null hypothesis. That is, Z null follows a multivariate normal distribution with mean 0 and variance–covariance matrix R , where R can be estimated by LD among
the genetic variants in a gene using external reference panels (i.e., 1000 Genomes Project).
Step 2: We use the regularization procedure to obtain the corrected correlation matrix of Z-scores Û . Then,
k(b)

k(b)

k(b)

k(b)

k(b)

k(b)

we calculate QBT , QSKAT , QSKATO and the corresponding p-values pBT , pSKAT , pSKATO using the simulated Z null
k(b)

k(b)

k(b)

for k = 0, 1, . . . , K . The distributions of QBT , QSKAT , QSKATO depend on the corrected correlation matrix Û, and
the standardized eQTL—derived weights Wk for k = 0, 1, . . . , K .
To estimate the correlation matrix of p-values  used in the Overall method, we use the sample correlation
matrix of the p-values obtained from the replications. We denote the sample correlation matrix of p-values as
ˆ . For example, 
ˆ which is the estimated correlation between BT and SKAT without
ˆ 12 is the (1,2)-element of 



0(1)

0(B) T

using any weights. If we let p0BT = pBT , . . . , pBT
be a B × 1 vector of the p-values of BT without using any
T

0(B)
0(1)
0
weights and pSKAT = pSKAT , . . . , pSKAT be a B × 1 vector of the p-values of SKAT without using any weights
obtained from
the replications,
then the sample correlation of p-values between these two tests is defined as


ˆ 12 = cor p0 , p0

BT SKAT , where cor(·) is the sample correlation.
The estimation procedure to estimate  is independent of our proposed method, therefore we only need to
perform this procedure once for each gene. After we estimate , the p-value of Overall can be computed analytically without using permutations.
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Study

Tissue

# of samples

References

NTR

Peripheral blood

1247

Wright et al.28

YFS

Whole blood

1264

Gusev et al.12

METSIM

Adipose

563

Gusev et al.12

CMC

Brain

452

Gusev et al.12

Table 1.  Resources of the four eQTL—derived weights used in the simulation studies.

Simulation studies

Materials and comparison methods. In our studies, we use four data sets to obtain the eQTL—derived
weights downloaded from the functional summary-based imputation website (http://gusevlab.org/projects/
fusion/#reference-functionaldata). The resources to obtain the four eQTL—derived weights are listed in Table 1.
For each eQTL data set, we use the weights estimated by the Best Linear Unbiased Prediction (BLUP)27.
We compare our proposed method with three existing methods, O
 T15, S-PrediXcan29, and S-TWAS12. These
three methods are all based on GWAS summary statistics and incorporate eQTL‐derived weights. Here, we
briefly introduce these three methods.
OT: For a total of K different eQTL—derived weights and the three gene-based association tests (BT, SKAT, SKATO), OT aggregates information from different weights and
tests by using the Cauchy combination 
m ethod 30 . The test statistic of OT is defined as





 

 

K
1
k π + tan
k
k
0.5 − pBT
0.5 − pSKAT
π + tan 0.5 − pSKATO
π and the corQOT = 3(K+1)
k=0 tan
responding p-value of the test statistic can be approximated by pOT =

1
2

−

arctan (QOT )
.
π



k , the test
S-PrediXcan: For a given eQTL‐derived weight, provided by a matrix Wk = diag W1k , . . . , WM


k
k σ̂ Z
= m Wm
statistic of S-PrediXcan is defined as ZS−PrediXcan
m m σ̂ , where σ̂m is the estimated standard devia-

expression of a gene.
tion of the mth SNP in a gene and σ̂ is the estimated standard deviation

  k of the predicted
k
 , where �(·) is the standard
The p-value of S-PrediXcan can be computed as pS−PrediXcan
= 2 −ZS−PrediXcan
normal CDF function.


k T , the test statistic of
S-TWAS: For a given eQTL‐derived weight, provided by a vector w k = W1k , . . . , WM
T
w ·Z
k
, where R is the estimated LD structure among the genetic variants
S-TWAS is defined as ZS−TWAS
=  Tk
w k ·R·w k

  k
k
.
in a gene and the corresponding p-value can be calculated by pS−TWAS
= 2 −ZS−TWAS

The number of replications needed in estimation of . To apply our proposed method, we first
need to estimate the correlation matrix of p-values, , under the null hypothesis for each gene. Following the
estimation procedure introduced in the method section, we generate Z-scores instead of generating individuallevel genotype and phenotype data. To determine the number of replications needed in the estimation of ,
we consider 18 genes that contain different numbers of SNPs and have different LD structures. Supplementary
Table S1 gives a summary of these 18 genes. We can see from Supplementary Table S1, the number of SNPs in a
gene is ranging from 23 to 359 and the average per-SNP LD score in a gene is ranging from 12.72 to 170.85. We
simulate a Z-score vector from a multivariate normal distribution with mean 0 and variance–covariance matrix
R , Z ∼ MVN(0, R), where R is the LD matrix of each gene which can be estimated using the 1000 Genomes
Project (unrelated Europeans in 1000 Genomes in Phase 3; ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/). First, we
ˆ.
use B = 104 replications to estimate  under the null hypothesis, where the estimated matrix is denoted by 
ˆ 0 as the correlation matrix of p-values by using B0 replications. We vary the value of B0 from 16
Then, we denote 
ˆ 0 and 
ˆ , are the same by using “lavaan”
to 5000, and test the null hypothesis that the two correlation matrices, 
package (https://CRAN.R-project.org/package=lavaan)31. Supplementary Figure S1 shows that the p-values for
the hypothesis testing in each gene are greater than 0.05 after B0 = 1000 replications for all of the 18 genes.
ˆ for each gene under the null hypothesis. ConTherefore, we recommend using 1000 replications to obtain 
sequently, 1000 replications are used in the following sessions to evaluate the type I error rates and powers of
Overall.
Type I error rates. To evaluate if our proposed method can control type I error rates, we perform simula-

tions based on the aforementioned 18 genes. For each of the 18 genes, we generate Z-score vectors under the
null hypothesis, Z ∼ MVN(0, R), where R is the LD matrix of the gene estimated using the 1000 Genomes
project. Then, we use the regularization procedure to obtain the corrected correlation matrix of Z-scores Û ,
and calculate the three types of gene-based association tests, BT, SKAT, and SKATO, with or without the four
eQTL—derived weights (NTR, YFS, METSIM, CMC) based on the corrected correlation matrix Û . Finally, we
ˆ , with
apply our proposed method to combine the p-values using the estimated correlation matrix of p-values, 
1000 replications.
We generate simulated data to mimic real lipids data which we will use in “Real data analysis” section. Gene
AGTRAP is associated with lipids trait HDL15, There are a total of 23 genetic variants in gene AGTRAP. The LD
block structure of these 23 genetic variants is shown in Supplementary Fig. S2. Supplementary Figure S3 shows
ˆ for this gene. We use 107 replications to evaluate type I error rates of Overall
the estimated correlation matrix 
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α-level

5 × 10−2

1 × 10−2

1 × 10−3

1 × 10−4

1 × 10−5

1.75 × 10−6

BT0

5.03 × 10−2

1.06 × 10−2

1.00 × 10−3

1.01 × 10−4

9.76 × 10−6

1.84 × 10−6

SKAT0

5.24 × 10−2

1.07 × 10−2

1.01 × 10−3

1.00 × 10−4

1.04 × 10−5

1.80 × 10−6

SKATO0

4.58 × 10−2

9.57 × 10−3

1.02 × 10−3

1.04 × 10−4

9.72 × 10−6

1.46 × 10−6

BTCMC

5.17 × 10−2

1.04 × 10−2

1.01 × 10−3

9.82 × 10−5

9.58 × 10−6

1.72 × 10−6

SKATCMC

5.08 × 10−2

9.89 × 10−3

9.71 × 10−4

9.75 × 10−5

9.48 × 10−6

1.66 × 10−6
2.14 × 10−6

SKATOCMC

5.16 × 10−2

1.09 × 10−2

1.17 × 10−3

1.21 × 10−4

1.22 × 10−5

BTMETSIM

5.02 × 10−2

1.03 × 10−2

1.02 × 10−3

1.01 × 10−4

9.86 × 10−6

1.66 × 10−6

SKATMETSIM

5.30 × 10−2

1.08 × 10−2

1.02 × 10−3

9.91 × 10−5

1.00 × 10−5

2.12 × 10−6

SKATOMETSIM

4.84 × 10−2

1.05 × 10−2

1.11 × 10−3

1.09 × 10−4

1.06 × 10−5

1.84 × 10−6

BTNTR

5.02 × 10−2

1.06 × 10−2

1.00 × 10−3

9.93 × 10−5

1.01 × 10−5

1.76 × 10−6

SKATNTR

5.09 × 10−2

1.03 × 10−2

9.98 × 10−4

1.00 × 10−4

1.01 × 10−5

2.00 × 10−6

SKATONTR

5.08 × 10−2

1.18 × 10−2

1.34 × 10−3

1.45 × 10−4

1.52 × 10−5

2.92 × 10−6

1.05 × 10−5

2.10 × 10−6

BTYFS

5.10 × 10−2

1.02 × 10−2

9.95 × 10−4

9.95 × 10−5

SKAT YFS

4.98 × 10−2

1.03 × 10−2

9.97 × 10−4

1.01 × 10−4

1.02 × 10−5

2.06 × 10−6

SKATOYFS

5.58 × 10−2

1.32 × 10−2

1.43 × 10−3

1.55 × 10−4

1.69 × 10−5

3.50 × 10−6

Overall

4.67 × 10−2

1.01 × 10−2

1.12 × 10−3

1.14 × 10−4

1.24 × 10−5

2.44 × 10−6

Table 2.  Estimated type I error rates at different significance levels with 107 replications. The subscript denotes
BT, SKAT, and SKATO using eQTL—derived weights; CMC, METSIM, NTR, and YFS indicate the resources
to obtain the eQTL—derived weights. 0 indicates the methods without using eQTL—derived weights.

for gene AGTRAP at 5 × 10−2, 1 × 10−2, 1 × 10−3, 1 × 10−4,1 × 10−5, and 1.75 × 10−6 significance levels. With
107 replications, a Bonferroni corrected significance level of 1.75 × 10−6 can be reached to obtain the empirical
type I error rates (i.e., for 28,625 genes in the real data analysis section, the Bonferroni corrected significance
level is 0.05/28625 = 1.75 × 10−6 at 5% significance level). We further evaluate type I rates based on the other
17 genes. To save computational time, we use 2 × 105 replications to evaluate type I error rates of Overall for the
17 genes at significance levels of 1 × 10−2, 1 × 10−3, and 1 × 10−4 . Table 2 and Supplementary Table S2 show
the estimated type I error rates of Overall under various nominal significance levels for gene AGTRAP and the
other 17 genes, respectively. From these tables, we can see that our proposed method can control type I error
rates very well at different significant levels.

Power comparison. To evaluate the performance of the Overall method, we use several simulations to
compare the power of Overall with the power of OT, S-PrediXcan, S-TWAS, and three types of gene-based association tests with and without eQTL—derived weights. We use BEST to represent the test with the maximum
power among the three traditional gene-based association tests with and without an eQTL—derived weight,
S-TWAS.B and S-PrediXcan.B to represent the maximum power of S-TWAS and S-PrediXcan with each of the
eQTL—derived weights, respectively. Following the simulation settings in Nagpal et al.32 and Zhang et al.15, we
generate individual-level genotypes, phenotypes, and different gene expression levels using the following steps:
(1)

The genotype data are generated using the haplotypes of a gene obtained from the 1000 Genomes Project
reference panel. To generate the genotype of an individual, Xg , we select two haplotypes according to the
haplotype frequencies from the haplotype pool and then remove genetic variants with MAF < 0.05.
(2) We consider K different weights derived from gene expression data which can be estimated using BLUP.
To generate a vector of weights, w k , for the kth gene expression level, we randomly select causal variants
according to the proportion of causal variants, pcausal . Then, the effect sizes for the kth gene expression
levels and Mcausal causal variants can be generated from a standard normal distribution, wmk ∼ N(0, 1)
for m = 1, . . . , Mcausal , where Mcausal = M × pcausal ; otherwise, wmk = 0. After we rescaled the weights to
ensure the targeted expression heritability h2e , we generate the
 kth gene expression level by E k = Xg w k + εe
with each element of random error εe follows N 0, 1 − h2e .
(3) Let E = (E 1 , . . . , E K ) be the matrix of gene expression levels. Phenotypes
are
 generated by using a formula

Y = Eβ + εp with each element of random error εp follows N 0, 1 − h2p , where β = (β1 , . . . , βK )T is a
vector of genetic effect sizes which can be assigned based on the phenotypic heritability h2p.
(4) The Z-score vector is estimated from individual-level genotype and phenotype data using beta coefficient
and its standard deviation estimated based on the ordinary least squares method in linear regression.

In our simulation studies for power comparison, we consider two genes, AGTRAP and C3orf22, from the 18
genes used in the type I error evaluation and K = 4 and K = 20 eQTL—derived weights. AGTRAP contains 458
haplotypes for 23 genetic variants (11 common variants and 12 rare variants; MAF ranging from 0 to 0.39775);
C3orf22 contains 295 haplotypes for 42 variants (18 common variants and 24 rare variants; MAF ranging from 0
to 0.43558). Supplementary Figure S2 shows the LD block structure of the 23 genetic variants at AGTRAP and the
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Figure 1.  Power comparisons of gene-based association tests at 1.75 × 10−6 significance level under Unidirectional effects (β1 = β2 = β3 = β4) with pcausal = (0.2, 0.3, 0.4, 0.5) based on gene AGTRAP. (a) Estimated
power against phenotypic heritability h2p with fixed expression heritability h2e = 0.2; (b) Estimated power against
expression heritability h2e with fixed phenotypic heritability h2p = 0.2.

Figure 2.  Power comparisons of gene-based association tests at 1.75 × 10−6 significance level under
Bi-directional effects (β1 = β2 = −β3 = −β4) with pcausal = (0.2, 0.3, 0.4, 0.5) based on gene AGTRAP. (a)
Estimated power against phenotypic heritability h2p with expression heritability h2e = 0.2; (b) Estimated power
against expression heritability h2e with phenotypic heritability h2p = 0.2.
42 genetic variants at C3orf22. We vary the proportion of causal variants with values pcausal = (0.2, 0.3, 0.4, 0.5) for
AGTRAP and pcausal = (0.1, 0.2, 0.3, 0.4) for C3orf22. We also consider two different directions of genetic effects:
β1 = · · · = βK (Scenario 1: Uni-directional effects) and β1 = · · · = βK/2 = −βK/2+1 = · · · = −βK (Scenario
2: Bi-directional effects). For each simulation scenario, we vary the proportion of gene expression heritability

Scientific Reports |
Vol:.(1234567890)

(2022) 12:3553 |

https://doi.org/10.1038/s41598-022-07465-0

6

www.nature.com/scientificreports/
and the phenotypic heritability with different values of h2e and h2p. We consider the sample size to be 2000 (unless
it is specified) and the power is calculated as the proportion of 1000 replications with p-value < 1.75 × 10−6.
Figure 1 (Supplementary Fig. S4) show the power comparisons based on gene AGTRAP (and C3orf22) with
K = 4 under the Uni-directional effects (β1 = β2 = β3 = β4 ) with different pcausal . We consider two settings
here. First, we vary phenotypic heritability h2p with a fixed expression heritability h2e = 0.2 (Fig. 1a and Supplementary Fig. S4a). Second, we vary the expression heritability h2e with a fixed phenotypic heritability h2p = 0.2
(Fig. 1b and Supplementary Fig. S4b). Figure 2 (Supplementary Fig. S5) shows power comparisons based on gene
AGTRAP (and C3orf22) under the Bi-directional effects (β1 = β2 = −β3 = −β4) with different pcausal for K = 4.
We also consider two simulation settings, power against the phenotypic heritability h2p with a fixed expression
heritability h2e = 0.2 and power against the expression heritability h2e with a fixed phenotypic heritability h2p = 0.2.
The pattern of the power in Fig. 2 (Supplementary Fig. S5) is similar to what we observe in Fig. 1 (Supplementary Fig. S4). These figures show that (1) Overall and OT perform uniformly better than BEST, S-TWAS.B, and
S-PrediXcan.B. We can see that Overall and OT boost power significantly due to integrating association evidence
by different traditional tests and multiple eQTL—derived weights. Overall is slightly more powerful than OT in
all of the scenarios. (2) Among BEST, S-TWAS.B, and S-PrediXcan.B, BEST is more powerful than S-TWAS.B
and S-PrediXcan.B in all of the scenarios for gene C3orf22; For gene AGTRAP, S-TWAS.B and S-PrediXcan.B
perform better than BEST when the proportion of causal variants in a gene is small ( pcausal = (0.2, 0.3)); otherwise, BEST performs better than S-TWAS.B and S-PrediXcan.B.
To evaluate if Overall and OT that integrate different types of association tests and multiple eQTL—derived
weights are robust for more eQTL studies, we also consider 20 ( K = 20) eQTL—derived weights under Unidirectional effect and Bi-directional effect models on gene C3orf22 with settings similar to the settings in Supplementary Figs. S4 and S5. After integrating L = 3(K + 1) = 63 traditional gene-based association tests, we
observe that the patterns of the power for K = 20 are similar to that in Supplementary Figs. S4 and S5 with
K = 4, and the power gain of Overall and OT is higher than that of the tests only consider one eQTL—derived
weight, such as BEST, S-PrediXcan.B, and S-TWAS.B (Supplementary Fig. S6).
Furthermore, we consider simulation settings with noise to the eQTL. We consider simulation settings by
adding less noise to the eQTL from the most relevant tissues and more noise to those from the less relevant tissues. For the Uni-direction scenario, we consider the first study 
being the most relevant tissue, where





β1 = β0 + N 0, 0.1h2p and β2 = β3 = β4 = β0 + N 0, 0.5h2p ; β0 = h2p K depends on the phenotypic heritability h2p. For the Bi-direction scenario, we consider the first and third
 studies being the mostrelevanttissues
β
=
−β
+
N
0, 0.1h2p , β3 = β0 + N 0, 0.1h2p , and
that have opposite
effect
directions,
where
1
0





β2 = −β0 + N 0, 0.5h2p , β4 = β0 + N 0, 0.5h2p . Other parameter settings are the same as these in Supplementary Figs. S4 and S5. The power comparison results are shown in Supplementary Figs. S7 and S8. From these
figures, we find that the patterns of the power in Supplementary Figs. S7 and S8 are very similar to those in
Supplementary Figs. S4 and S5.
In all of the previous power comparisons, we use a sample size of 2000. We also consider simulation settings as
those in Supplementary Figs. S7 and S8, but with a large sample size of 100,000. Supplementary Figure S9 shows
the results of power comparisons. We can see from this figure, all powers are increased with this larger sample
size, but the patterns of the power are very similar to those in Supplementary Figs. S7 and S8.
To remove noise in LD matrix computed from a reference sample, we shrink the observed LD matrix toward
an identity matrix with the shrinkage parameter estimated by maximum likelihood. To evaluate how well this
regulation process performs, we compare the powers of three traditional gene-based association tests with and
without eQTL—derived weights, OT, and Overall based on corrected and uncorrected LD structure. We use the
same simulation settings as those in Supplementary Figs. S7 and S8. Supplementary Figure S10 shows the power
comparison results based on gene C3orf22 under Uni-directional effects and Bi-directional effects with noise
to eQTL. We can see that the powers of these tests based on corrected LD structure perform better than those
based on uncorrected LD structure in most of the settings.

Real data analysis

To evaluate the performance of our proposed method, we apply Overall, OT, the three traditional tests with and
without eQTL—derived weights, S-PrediXcan, and S-TWAS to the GWAS summary statistics data sets used in
Zhang et al.15: two SCZ GWAS summary data sets and two lipid GWAS summary data sets. We estimate the LD
between genetic variants using the 1000 Genomes Project reference p
 anel16, and obtain the corrected matrix of
Z-score after the regularization procedure. We consider four eQTL—derived weights estimated by the BLUP
method using the resources listed in Table 1 (NTR, YFS, METSIM, CMC).

Application to the SCZ GWAS summary data.

We consider two SCZ GWAS summary data sets, SCZ1
and SCZ2, which can be downloaded from the Psychiatric Genomics Consortium website (https://www.med.
unc.edu/pgc/results‐and‐downloads/)33. SCZ1 is a meta-analysis of SCZ GWAS data set with 13,833 cases and
18,310 controls. SCZ2 is a more recent and larger SCZ GWAS summary data set with 36,989 cases and 113,075
controls for partial v alidation34. In our real data analysis, we define a gene to include all of the SNPs from 20 kb
upstream to 20 kb downstream of the gene and test the association between each gene and the trait. We consider all genes according to the GENCODE version 35 (GRCh37) human comprehensive gene annotation list
which can be downloaded from the GENCODE website (https://www.gencodegenes.org/human/release_35lif
t37.html).
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SCZ2
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7

1

38

SKAT0

47

305

20

15

153
153

136

394

27

15

BTCMC

44

137

2

1

56

SKATCMC
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225

6

1

134

SKATOCMC

30

263

2

1

130

BTMETSIM

44

136

5

1

48

SKATMETSIM

23

223

9

4

132

SKATOMETSIM

31

205

3

0

100

BTNTR

48

119

7

6

48

SKATNTR

27

230

9

8

141

SKATONTR

40

280

8

6

143

BTYFS

89

166

14

1

53

SKATYFS

20

223

6

7

137

SKATOYFS

47

321

7

0

140

S-PrediXcanCMC

42

43

7

0

38

S-PrediXcanMETSIM

41

44

8

1

30

S-PrediXcanNTR

48

70

14

6

59

S-PrediXcanYFS

83

128

29

2

72

S-TWASCMC

33

45

6

0

43

S-TWASMETSIM

36

29

5

1

20

S-TWASNTR

37

54

13

6

46

S-TWASYFS

64

105

29

2

58

OT

133

522

17

6

166

Overall

271

559

45

16

167

SKATO0

Table 3.  The numbers of genes identified by each method for the two SCZ data sets. The subscript denotes
BT, SKAT, and SKATO using eQTL—derived weights; CMC, METSIM, NTR, and YFS indicate the resources
to obtain the eQTL—derived weights. 0 indicates the methods without using any weights. SCZ1 indicates the
number of genes identified by each method for SCZ1 data; SCZ2 indicates the number of genes identified by
each method for SCZ2 data; SCZoverall indicates the number of overlapping genes identified by both SCZ1 and
SCZ2 data sets; GWASSCZ1 and GWASSCZ2 indicate the numbers of genome-wide significant genes that are
reported in the GWAS catalog and are also identified by each method for SCZ1 and SCZ2, respectively.

Figure 3.  Venn diagram of the number of genes identified by Overall, OT, and S KATO0, S-PrediXcanYFS, and
S-TWASYFS for SCZ1 data (left) and SCZ2 data (right). The number below each method indicates the total
number of significant genes identified by the corresponding method.

To make fair comparisons among all these weighted tests, the genetic variants are removed if there is at least
one weight missing in the four eQTL—derived weights. After pruning, there are 26,575 genes in SCZ1 and 17,823
genes in SCZ2 left in our final analyses. Therefore, the Bonferroni corrected significance level for gene-based
association analysis is defined as 0.05 divided by the number of genes. First, we apply BT, SKAT, and SKATO
with and without an eQTL—derived weight, OT, Overall, S-PrediXcan, and S-TWAS to the SCZ1 and SCZ2
data sets. Table 3 (SCZ1 and SCZ2) shows the number of genes identified by each method for the SCZ data sets,
respectively. As we can see in Table 3, Overall identifies more genes than all of the other methods for two SCZ
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Data
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References

RAI1

SCZ1

2.63E−31

Pardiñas et al.35

SLC7A6

SCZ1

2.17E−15

Ikeda et al.36; Li et al.37

AP001931.2

SCZ1

1.27E−13

Schizophrenia Working Group of the Psychiatric Genomics Consortium34; Goes et al.38; Ikeda et al.36;
Li et al.37; Lam et al.39; Periyasamy et al.40; Lee et al.41; The Autism Spectrum Disorders Working Group
of the Psychiatric Genomics Consortium42; Pardiñas et al.35

MARK2

SCZ1

2.64E−07

Goes et al.38

GULOP

SCZ1

1.24E−07

Pardiñas et al.35; Ikeda et al.36; Li et al.37; Goes et al.38; Lam et al.43

ZBED4

SCZ1

9.02E−07

Goes et al.38

RAB11FIP5

SCZ2

1.05E−06

Goes et al.38; Lam et al.43

AL669918.1

SCZ2

2.03E−06

Goes et al.38

YPEL1

SCZ2

2.80E−06

Goes et al.38

LINC00606

SCZ2

2.57E−06

Goes et al.38

ERLIN1

SCZ2

2.34E−06

Goes et al.38

AC024597.1

SCZ2

2.56E−06

Lam et al.39

Table 4.  Genes identified only by Overall based on the two SCZ data sets that are reported in the GWAS
catalog.

GWAS summary data sets. Among the three types of gene-based association tests, BT, SKAT, and SKATO, with
or without different eQTL—derived weights, S KATO0 identifies the largest number of genes. S-TWASYFS and
S-PrediXcanYFS identify the largest number of genes compared with S-TWAS and PrediXcan based on the other
three eQTL—derived weights, respectively. Therefore, in Fig. 3, we only show the number of genes identified
by Overall, OT, S KATO0, S-PrediXcanYFS, and S-TWASYFS. The number below each method indicates the total
number of genes identified by the corresponding method. From Fig. 3, we can see that Overall identifies all of
the genes identified by OT for SCZ1; for SCZ2, there are two genes identified by OT but failed to be identified
by Overall; there are 66 and 24 genes identified only by Overall for SCZ1 data and SCZ2, respectively.
We further investigate the 90 genes identified only by Overall for the SCZ data sets by searching the GWAS
catalog (https://www.ebi.ac.uk/gwas/). Among the 66 genes for the SCZ1 data set, there are six genes reported
in the GWAS catalog; among the 24 genes for the SCZ2 data set, there are six genes reported in the GWAS
catalog (Table 4). We also use these two SCZ GWAS data sets for partial validation. Table 3 shows that there
are 45 overlapping genes identified by Overall using SCZ1 and SCZ2 data sets and only 17 overlapping genes
identified by OT using both SCZ1 and SCZ2 data sets. Furthermore, we search for genome-wide significant
SNPs ( p < 5 × 10−8) from the two SCZ GWAS summary data sets and consider the genes covering at least one
genome-wide significant SNP from 20 kb upstream to 20 kb downstream of the gene. There are 63 genomewide significant genes for SCZ1, and 2422 genome-wide significant genes in SCZ2. Table 3 (GWASSCZ1 and
GWASSCZ2) summarizes the numbers of genome-wide significant genes that are identified by each method for
the two SCZ data sets. Among the 63 genome-wide significant genes for the SCZ1 data set, Overall identifies the
largest number of genes, followed by SKAT0 and SKATO0; OT, S-PrediXcanNTR and S-TWASNTR only identify
6 genes. Meanwhile, among 2422 genome-wide significant genes for SCZ2, Overall identifies 167 genes; OT
identifies 166 genes; SKATO and S KATO0 identify 153 genes; S-TWASYFS and S-PrediXcanYFS only identify 58
and 72 genes respectively.

Application to the lipids GWAS summary data. We consider two lipids GWAS summary data sets,
HDL1 and HDL2, which can be downloaded at the Center for Statistical Genetics (CSG) at the University of
Michigan. HDL1 is a meta-analysis of HDL GWAS data set with about 100,000 samples downloaded at the
website (http://csg.sph.umich.edu/willer/public/lipids2010/)44. HDL2 is the follow-up data with about 189,000
samples for partial validation downloaded at the Global Lipids Genetics Consortium (http://csg.sph.umich.edu/
willer/public/lipids2013/)45. We perform the same analysis as we did in the previous section for the two SCZ
GWAS summary data sets. After pruning and removing the genetic variants with missing weights, there are
17,389 genes in HDL1 and 16,917 genes in HDL2. Table 5 (HDL1 and HDL2) shows the number of genes
identified by each method for the two lipids data sets, respectively. As we can see from Table 5, among the three
traditional gene-based association tests with and without eQTL—derived weights, SKATO0 and BT0 identify the
largest number of genes in HDL1 and HDL2, respectively; Among the four S-PrediXcan tests, S-PrediXcanYFS
and S-PrediXcanCMC identify the largest number of genes in HDL1 and HDL2, respectively; for the four S-TWAS
tests, S-TWASYFS and S-TWASCMC identify the largest number of genes in HDL1 and HDL2, respectively. For the
HDL1 data set, Overall identifies the largest number of genes (249), followed by OT that identifies 233 genes;
for the HDL2 data set, B
 T0 identifies the largest number of genes (836), followed by Overall and OT, where
Overall identifies 765 genes and OT identifies 688 genes. In Fig. 4, we compare genes identified by SKATO0,
S-PrediXcanYFS, and S-TWASYFS, along with Overall and OT for the HDL1 data set and genes identified by B
 T0,
S-PrediXcanCMC, S-TWASCMC, Overall, and OT for the HDL2 data set. Again, we observe that Overall identifies
the largest number of genes for the HDL1 data set and the second most for the HDL2 data set; all genes identified by OT are also identified by Overall; 82 and 24 genes are identified only by Overall and OT for the HDL1
and HDL2 data sets, respectively; there are 13 and 6 genes only identified by Overall for the HDL1 and HDL2
data sets, respectively. We search the GWAS catalog (https://www.ebi.ac.uk/gwas/). Table 6 shows that five out
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SKATMETSIM

120

259

118

102

149
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111
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53
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BTNTR
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142

185
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99

144
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43
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18

29

114

S-PrediXcanMETSIM

45

201

23

30

118

S-PrediXcanNTR

33

187

14

19

108

S-PrediXcanYFS

69

195

25

31

117

S-TWASCMC

40

207

17

23

109

S-TWASMETSIM

37

202

16

15

112

S-TWASNTR

25

176

10

11

97

S-TWASYFS

59

183

24

29

115

OT

233

688

167

120

190

Overall

249

765

177

122

192

Table 5.  The number of genes identified by each method for the two lipids data sets. The subscript denotes
BT, SKAT, and SKATO using eQTL—derived weights; CMC, METSIM, NTR, and YFS indicate the resources
to obtain the eQTL—derived weights. 0 indicates the methods without using any weights. HDL1 indicates the
number of genes identified by each method for HDL1 data; HDL2 indicates the number of genes identified by
each method for HDL2 data; HDLoverall indicates the number of overlapping genes identified by both HDL1
and HDL2 data sets; GWASHDL1 and G
 WASHDL2 indicate the numbers of genome-wide significant genes that
are reported in the GWAS catalog and are also identified by each method for HDL1 and HDL2, respectively.

Figure 4.  Venn diagram of the number of genes identified by Overall, OT, S KATO0, S-PrediXcanYFS, and
S-TWASYFS for HDL1 data (left) and Overall, OT, B
 T0, S-PrediXcanCMC, and S-TWASCMC for HDL2 data (right).
The number below each method indicates the total number of significant genes identified by the corresponding
method.

of 13 genes identified only by Overall based on HDL1 data have been reported, and one out of 6 genes has been
reported on HDL2 data in the GWAS catalog. We also use these two HDL GWAS data sets for partial validation
by looking for the number of overlapping genes identified by both of the data sets (Table 5, HDLoverlap). There are
177 overlapping genes identified by Overall for both SCZ1 and SCZ2 data sets and 167 overlapping genes identified by OT for both SCZ1 and SCZ2 data sets.
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AP002954.1

HDL1

2.27E−11

Emilsson et al.46

EDC4

HDL1

1.65E−11

Lettre et al.47, Kilpeläinen et al.48, Wojcik et al.49

PACSIN1

HDL1

2.24E−06

Liu et al.50

AFF1

HDL1

2.10E−06

Spracklen et al.51, De Vries et al.52, Hoffmann et al.53, Ripatti et al.54, Richardson et al.55

AC106779.1

HDL1

2.85E−06

Noordam et al.56

NHLRC2

HDL2

1.98E−06

Hoffmann et al.53, Richardson et al.55, Klarin et al.57, Qi et al.58, Klimentidis et al.59, Liu et al.60

Table 6.  Genes identified only by Overall based on the two lipids data sets that are reported in the GWAS
catalog.

Same as the analyses for the SCZ GWAS summary data sets, we search for genome-wide significant SNPs
( p < 5 × 10−8) from the two lipids GWAS summary statistics. There are 1911 genome-wide significant genes
for HDL1 and 2682 genome-wide significant genes for HDL2. Table 5 (GWASHDL1 and GWASHDL2) summarizes
the numbers of genome-wide significant genes that are identified by each method for the two lipids data sets.
Among the 1911 genome-wide significant genes for the HDL1 data set, Overall identifies the largest number of
genes (122), followed by OT (120), then S KAT0 (104); S-TWASYFS only identifies 29 genes and S-PrediXcanYFS
identifies 31 genes. Meanwhile, among 2682 genome-wide significant genes for HDL2, Overall identifies the largest number of genes (192); OT and S KATO0 identify 190 genes; S-TWASMETSIM and S-PrediXcanMETSIM identify
112 and 118 genes. respectively.

Discussions

In this paper, we develop a powerful and computationally efficient method, Overall, for gene-based association
studies using GWAS summary data. Overall aggregates information from three traditional types of gene-based
association tests (BT, SKAT, SKATO) and also incorporates eQTL data. Both our simulation studies and real data
analysis confirm that our proposed method can control type I error rates correctly and has very good performance compared with other comparison methods. In “Real data analysis”, Overall identify more significant genes
than other methods, and there are some genes reported by GWAS catalog which are only identified by Overall.
There are some advantages of our proposed method. First, Overall adaptively aggregates information from
multiple gene-based association tests. Most combination tests (i.e., Fisher’s combination t est61) assume that the
p-values should be calculated from independent tests. To combine information from highly correlated gene-based
association tests, Overall utilizes the extended Simes procedure5,22. It is shown that this procedure to combine
multiple tests is stable and effective regardless of whether the tests are highly correlated24,62. Second, Overall
is more powerful than the traditional gene-based association tests, some popular transcriptome association
tests (i.e., S-PrediXcan29 and S-TWAS12), and other eQTL weighted combination tests (i.e., ominous t est15). By
aggregating information from different tests and incorporating multiple eQTL—derived weights, Overall can
achieve a higher statistical power under a variety of situation settings. Meanwhile, our simulation studies and real
data analyses show that the extended Simes procedure is more powerful than the Cauchy combination method,
especially if the proportion of causal variants in a gene is small. Third, the p-values of Overall can be analytically
computed without using permutations, therefore, Overall is computationally efficient. Finally, using the regularization procedure to correct the estimated LD can reduce the potential statistical noise in the LD estimation
if LD is estimated using a reference panel with small sample size. In addition, Overall can be easily applied to
genetic association studies with either individual-level data or GWAS summary statistics.
In this paper, we combine three types of traditional gene-based association tests (BT, SKAT, SKATO). However, the combination procedure used in the paper is very general. Other more powerful gene-based association
tests can also be combined using the same approach, such as some state-of-the-art methods (i.e., S-TWAS12,
E-MAGMA63, and SMR64).
In this current study, we utilize the weights derived from four single tissue gene expression studies (CMC,
METSIM, NTR, YFS). Although the extended Simes procedure in Overall allows us to employ more eQTL—
derived weights from a number of studies (i.e., GTEx gene expression version 865 et al.), there is a possibility
that the noise can be increased with the increment in the number of unrelated studies. Therefore, the power of
the combination tests (i.e., Overall and OT) might be attenuated. Thus, to obtain the most robust identification
of phenotypic associated genes in a real data analysis with the Overall method, we suggest incorporating eQTL
datasets from the most relevant tissues to the phenotype. The last but the most important thing is that population
stratification can be confounded association r esults66,67. Systematic minor allele frequency difference between
transcriptomic studies of different cohorts and no matching between the estimated LD structure of Genomes
Project with that in the study may increase the chances of false positive findings. Therefore, we need to eliminate
false positive findings possibly caused by population s tratification68,69. When applying the Overall method, the
population of GWAS summary dataset, external reference panel (i.e., 1000 Genomes Project) used to estimate
LD structure, and eQTL—derived weights should be consistent.
In this study, the computational time of the proposed method is acceptable even if the estimated correlation matrix of multiple tests is obtained by the replication procedure. Meanwhile, the estimation procedure is
independent of gene-based association tests, therefore we only need to perform this procedure once for each
GWAS summary dataset. For example, there are a total of 29,008 gene in the 1000 Genomes Project and we
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use 1000 replicates to estimate the correlation matrix of multiple tests for each gene. We perform this using the
high-performance computing (HPC) cluster (Intel Xeon E5—2670 2.6 GHz, 16 GB RAM). The computational
time for all genes is about 36 h CPU time with 500 nodes. Then, the p-value of the proposed method can be
computed analytically which is independently performed in each GWAS summary dataset. The computational
time for each GWAS dataset is about 1 h CPU time with 10 nodes.

Data availability

The data that support the findings of this study are publically available and the links to the data are provided in
the article.
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